OAM
VIVO

Oxford Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Oxford Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-163,346
Closed -$1.6M – 1505
2019
Q4 		$1.6M Sell
163,346
-137,324
-46% -$1.29M 0.04% 563
2019
Q3 		$2.85M Buy
300,670
+30,902
+11% +$326K 0.07% 356
2019
Q2 		$3.21M Buy
269,768
+92,900
+53% +$1.12M 0.07% 433
2019
Q1 		$3.12M Buy
176,868
+9,931
+6% +$165K 0.07% 377
2018
Q4 		$2.9M Sell
166,937
-40,370
-19% -$689K 0.08% 307
2018
Q3 		$3.08M Buy
207,307
+36,403
+21% +$564K 0.06% 423
2018
Q2 		$2.73M Buy
170,904
+28,125
+20% +$420K 0.05% 474
2018
Q1 		$2.03M Buy
142,779
+28,557
+25% +$423K 0.04% 569
2017
Q4 		$1.62M Sell
114,222
-43,863
-28% -$642K 0.03% 694
2017
Q3 		$2.25M Buy
158,085
+25,429
+19% +$363K 0.04% 565
2017
Q2 		$2.09M Buy
132,656
+55,110
+71% +$794K 0.04% 590
2017
Q1 		$1.07M Buy
+77,546
New +$1.08M 0.03% 778

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oxford Asset Management's VIVO Position: Q1 2020 in Review

Oxford Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 163,346 shares — an estimated $1.6M sold.

Oxford Asset Management first reported a position in VIVO in Q1 2017 and held it in 12 quarters. The position peaked at $3.21M in Q2 2019. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • Oxford Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 163,346 Meridian Bioscience Inc shares in Q1 2020, an estimated $1.6M.
  • Oxford Asset Management first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 12 quarters.
  • Oxford Asset Management's Meridian Bioscience Inc position peaked at $3.21M in Q2 2019.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.